Leadership

Our Leadership is driven by the highest standards.

Executive Team

Barb Jones, PhD
Chief Executive Officer
Jennifer Adams
Vice President, Standards & Quality
Cecilia Porto
Vice President, Finance & Accounting
Lisa Arone
Vice President, Global Communications & Brand
“Whether it’s the development of clinical standards or the delivery of rigorous education, training, and webinars, our work ensures the integrity and reliability of the tests that inform diagnosis. With our help, every patient begins the journey knowing their path has been built on the strongest of foundations.”
– Dr. Barb Jones
CEO, CLSI
Board of Directors

Active Advocates
for CLSI and its Vision

With balanced representation from government, industry, and the health care professions, the CLSI Board of Directors is dedicated to maintaining the integrity of the voluntary consensus process, promoting quality medical testing and health care services, and fulfilling the CLSI mission. 

Officers of the Board

Gary W. Procop, MD, MS, MEd
President, CLSI Board of Directors
Loralie J. Langman, PhD, DABCC, FACB, F-ABFT
President-Elect, CLSI Board of Directors
Joseph Passarelli
Treasurer, CLSI Board of Directors
Paula M. Snippes Vagnone, MT(ASCP)
Secretary, CLSI Board of Directors
James H. Nichols, PhD, DABCC, FADLM
Immediate Past President, CLSI Board of Directors
Barb Jones, PhD
Chief Executive Officer

CLSI Board of Directors

Lorin Bachmann, PhD, DABCC, MT(ASCP)
Virginia Commonwealth University Health System
Víctor R. De Jesús, PhD
US Centers for Disease Control and Prevention (CDC)
Jamie Phillips Deeter, MS, PhD
Roche Diagnostics
Randall T. Hayden, MD
St. Jude Children's Research Hospital
Debbie Kuehl MS, M(ASCP)
National Center for Immunization and Respiratory Diseases (NCIRD)
Michael J. Loeffelholz, Ph.D., D(ABMM)
Cepheid
Marianela Perez-Torres, MT, PhD
US Food and Drug Administration (FDA)
Lucy A. Perrone, MSPH, PHD
University of British Columbia (UBC)
Vicki Petrides, MS
Vicki Petrides, MS
Abbott Laboratories
Zahra Shajani-Yi, PhD, DABCC, FADLM
Labcorp
2024 Consensus Council

Stewardship for
the Consensus Process

The Consensus Council serves as the consensus body for CLSI. It assesses and prioritizes projects based on medical utility, clinical relevance, and CLSI’s mission. 

LDT Advisory Group

LDT Advisory Group

The LDT Advisory Group was formed to provide CLSI with additional subject-matter expertise and advice on the FDA LDT Final Rule regulatory requirements and laboratory implementation  to assist with and to support CLSI’s organizational response to the FDA LDT Final Ruling (May 2024). 

icon history

History

Founded in 1967, CLSI has been the global authority for international clinical and laboratory standards, cultivating best practices and fostering innovation through standards development, education, and training. 

icon star

Excellence Awards

CLSI Excellence Awards recognize the achievements of CLSI volunteers and organizational members who are committed to CLSI’s mission and have helped improve the quality of medical care worldwide.